Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association
Salim S. Hayek(Rush University Medical Center), Tochukwu Okwuosa(Rush University Medical Center), Vlad G. Zaha(Southwestern Medical Center), Anita Deswal(The University of Texas MD Anderson Cancer Center), Carmel Bogle(American Heart Association), Alexi Vasbinder(University of Washington), Eric H. Yang(University of California, Los Angeles), Amelia Langston(CancerCare Manitoba), Seth J. Rotz(Cleveland Clinic)
Cited by 38
Related Papers
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
|Journal of Clinical Oncology|2018|574
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2019|435
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416